Exocrine Pancreatic Insufficiency Market Growth Analysis: From US$ 2.48B to US$ 3.44B by 2034
Exocrine pancreatic insufficiency (EPI) is a chronic gastrointestinal condition that results from inadequate secretion of digestive enzymes by the pancreas, leading to malabsorption and nutritional deficiencies. It is commonly associated with diseases such as chronic pancreatitis, cystic fibrosis, and pancreatic cancer.  Global Exocrine Pancreatic Insufficiency Industry Size and Growth...
0 Reacties 0 aandelen 12 Views 0 voorbeeld